Weber William John's Form 4 filing
Calidi Biotherapeutics, Inc. (CLDI) · filed Sep 14, 2023
- Accession no.
- 0000899243-23-019095
- Filed
- Sep 14, 2023, 9:00 PM ET
- Trade date
- Jun 16-Sep 12, 2023
- Filing delay
- 90 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 5 derivative transactions. It was filed 90 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weber William JohnCIK 0001464648 | 10% Owner |
| First Light Acquisition Group, LLCCIK 0001855489 | 10% Owner |
| FLAG Sponsor Manager, LLCCIK 0001882920 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 | Common Stock, par value $0.0001 per share | CConversionAcquired | +1,931,852 | – | – | 1,931,852 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2023 | Class A Common Stock, par value $0.0001 per share | SSaleDisposed | −191,990 | – | – | 2,383,813 | Indirect | |
| Sep 12, 2023 | Class A Common Stock, par value $0.0001 per share | SSaleDisposed | −99,388 | – | – | 2,284,425 | Indirect | |
| Sep 12, 2023 | Class A Common Stock, par value $0.0001 per share | SSaleDisposed | −186,372 | – | – | 2,098,053 | Indirect | |
| Sep 12, 2023 | Class A Common Stock, par value $0.0001 per share | JOtherDisposed | −166,201 | – | – | 1,931,852 | Indirect | |
| Sep 12, 2023 | Class A Common Stock, par value $0.0001 per share | CConversionDisposed | −1,931,852 | – | – | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.